Protein biochemist (PhD) with research and teaching experience in nucleic acid and protein purification and characterization, experimental and clinical infections, blood coagulation, and blood vessel pathology. Biomanufacturing and biotechnology analytical method and process development experience with Resilience Biotechnologies (Mississauga, ON), Therapure Biopharma (Mississauga, ON) and bioMerieux (Durham, NC) and co-author of a research patent. First cloning and expression of the Calpain II gene (Rat). First production of monoclonal antibodies to Calpain I (Human). First to demonstrate that a complex of C-reactive protein (CRP) and very low density lipoprotein (VLDL) accounts for the biphasic transmittance waveform during severe infections (Sepsis) in humans and predicts system failure and mortality. Research publications in high impact factor journals - Journal of Biological Chemistry, Blood, and Journal of Thrombosis and Haemostasis. Research grants from - National Institutes of Health (NIH), Atomic Energy of Canada (AEC), Natural Sciences and Engineering Research Council of Canada (NSERC), PrioNet Canada, Bayer/Canadian Blood Services/Hema Quebec/Canadian Institutes of Health Research (CIHR) Partnership Fund, Bayer Blood Partnership Fund, and Bayer/Canadian Red Cross Research and Development Fund. Teaching and research laboratory supervisory experience in biochemistry, microbiology, hematology, blood coagulation and blood vessel pathology.